Association between the triglyceride–glucose index and subclinical atherosclerosis in asymptomatic adults: a large cross-sectional study of a health check-up population - Takeaways - MDSpire

Association between the triglyceride–glucose index and subclinical atherosclerosis in asymptomatic adults: a large cross-sectional study of a health check-up population

  • By

  • Zhihong Gao

  • Yuqiang Zuo

  • Yuling Yin

  • Xu Yang

  • Lei Xu

  • Min Jia

  • Lan Yang

  • June 10, 2026

  • 0 min

Share

  • 1

    The study involved 13,473 asymptomatic adults to assess the association between the triglyceride-glucose index and subclinical atherosclerosis.

  • 2

    Higher triglyceride-glucose levels were linked to increased odds of subclinical atherosclerosis in a dose-response manner.

  • 3

    Each 1-unit increase in the triglyceride-glucose index was associated with a 20% higher odds of subclinical atherosclerosis.

  • 4

    Participants in the highest tertile of triglyceride-glucose index had 38% higher odds of subclinical atherosclerosis compared to the lowest tertile.

  • 5

    The study found a significant non-linear association between triglyceride-glucose index and subclinical atherosclerosis, requiring further validation.

Original Source(s)

Association between the triglyceride–glucose index and subclinical atherosclerosis in asymptomatic adults: a large cross-sectional study of a health check-up population

  • by Zhihong Gao, Yuqiang Zuo, Yuling Yin, Xu Yang, Lei Xu, Min Jia, Lan Yang

  • June 10, 2026

Related Content

Case Report: Amiodarone-triggered refractory ventricular fibrillation storm in septic cardiomyopathy with pre-existing QT prolongation: termination using lidocaine and anisodamine

Case Report: Giant coronary artery aneurysm with cardiac compression successfully managed by surgical resection and bypass in a normolipidemic patient

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.